Workflow
Avis Budget Group Announces Chief Financial Officer Transition
Globenewswire· 2025-06-09 20:00
PARSIPPANY, N.J., June 09, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) today announced the appointment of Daniel Cunha as Chief Financial Officer, effective July 1, 2025. Mr. Cunha will lead ABG’s finance functions and partner with other senior leaders to set and deliver on the Company's long-term strategic and financial objectives. Izzy Martins will be leaving the Company on June 30, 2025, to pursue another opportunity. Mr. Cunha joins ABG from Orion Services Group, a private equity owne ...
Argyle Closes C$1 Million LIFE Offering
Newsfile· 2025-06-09 20:00
Calgary, Alberta--(Newsfile Corp. - June 9, 2025) - Argyle Resources Corp. (CSE: ARGL) (OTCQB: ARLYF) (FSE: ME0) ("Argyle" or the "Company") is pleased to announce that it has closed its previously announced offering of 2,000,000 units of the Company ("Units") at a price of C$0.50 per Unit, for aggregate gross proceeds up to C$1,000,000 (the "Offering"). Each Unit is comprised of one common share in the authorized share structure of the Company (a "Share") plus one-half of one Share purchase warrant (each ...
Visa: A Cornerstone Of My Portfolio Since 2016 - And Its Evolution Keeps Me Bullish
Seeking Alpha· 2025-06-09 19:50
Visa (NYSE: V ) has served as a cornerstone of my portfolio since 2016 and my conviction in the company and industry outlook has never wavered. It’s truly a ‘hold forever’ stock in my opinion. I haven’t addedEarly 30s 'buy and hold' investor trying to achieve financial freedom to the greatest extent possible. Main focus within dividend growth investing & value. I've been investing for 10+ years and worked across several industries including finance, logistics, oil and pharma. Holding a Graduate Diploma with ...
The More It Tanks, The More It Stanks
Seeking Alpha· 2025-06-09 19:42
When stocks offer high dividend yields that are fully covered by underlying income and trade at massive discounts to their net asset value, they often attract value-oriented high-yield investors. The reasoning is that by purchasing theseJoin Now to Access Our Top Picks for June 2025!Your timing is perfect! We’ve just released our latest top investment picks, and by joining today, you’ll gain immediate access to these exciting opportunities.We invest thousands of hours and over $100,000 annually into researc ...
Airstream and Frank Lloyd Wright Foundation Launch Limited Edition Travel Trailer
Prnewswire· 2025-06-09 19:35
Legendary American design icons blend signature engineering and architectural stylesJACKSON CENTER, Ohio, June 9, 2025 /PRNewswire/ -- Airstream®, the iconic manufacturer of world-class recreational vehicles, and the Frank Lloyd Wright Foundation have partnered to debut the Airstream Frank Lloyd Wright Usonian Limited Edition Travel Trailer. A tribute to American design and organic architecture, the limited-edition travel trailer personifies Frank Lloyd Wright's unmatched architectural vision and Airstream ...
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZeneca
CNBC· 2025-06-09 19:30
The Food and Drug Administration on Monday approved Merck's shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca.The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead of the RSV season that typically kicks off around fall and winter and lasts through the spring. Merck said in a release that it expects orders for the shot to begin in J ...
MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market
GlobeNewswire News Room· 2025-06-09 19:29
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology, LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans effic ...
Science Applications International Is a Wicked Hot Buy in June
MarketBeat· 2025-06-09 19:20
Science Applications International TodaySAICScience Applications International$103.52 -1.80 (-1.71%) 52-Week Range$94.68▼$156.34Dividend Yield1.43%P/E Ratio17.47Price Target$124.20Add to WatchlistScience Applications International's NYSE: SAIC share price imploded following Donald Trump’s election to the U.S. Presidency and is now offering a screaming hot entry for investors. The implosion was caused by uncertainty surrounding the company’s primary revenue source, government spending.Get SAIC alerts:Those ...
Walker Lane Resources Ltd. Receives TSX Approval for the Acquisition of Three Mineral Properties in the Walker Lane Gold Trend in Nevada from Silver Range Resources Ltd. and Auburn Gold
Globenewswire· 2025-06-09 19:17
VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) -- Walker Lane Resources Ltd. (TSX-V: WLR, “Walker Lane”) announces that it has received approval from the TSX Venture Exchange on its option agreements on three mineral properties (i.e., Tule Canyon, Cambridge and Silver Mountain – see location map Figure 1) located in the prolific Walker Lane Gold Trend of western Nevada. The original property agreements in the form of letters of intent (“LOI”), were signed with CMC Metals Ltd. now operating as W ...
ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal
Prnewswire· 2025-06-09 19:12
Significant Withhold Votes from Directors Mary Ann Gray and Alpna Seth Underscores Need for Change and a More Disciplined Capital Allocation StrategyAUSTIN, Texas, June 9, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "We"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company"), today issued the following statement regarding the results of the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting"):"We believe the ...